This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest
![](https://aptar.com/wp-content/uploads/2022/10/IPI_Oct2022_2.jpg)
Under Pressure: Finding a More Sustainable Future for pMDIs
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/07/Connected_Devices_Digital_Health_Digital_Therapeutics_Pharmapack_2022-1024x665.jpg)
Digital Health and Digital Therapeutics: Where are we heading and why?
Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/07/pMDIs_AsthmaAndCOPD_PharmaFile2022.jpg)
How pMDIs are transforming Asthma and COPD treatments
Publications, Pharmaceutical, Sustainability, Device Innovations, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/07/Thumbnail_Webinar_AptarDigitalHealthWebinar2022-1024x665.jpg)
Drug, Device, Digital: Reimagined Healthcare
Webinars, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions